Today the Court of Appeals for the District of Columbia Circuit heard oral arguments in the matter of Walgreen Co. v. Drug Enforcement Administration, et al., (Docket No. 12-1397). I will leave the prognosticating to trained professionals; however, it was clear to me that Walgreens was before a sympathetic panel. The three-judge panel asked
Significant Shift in Drug Diversion
Go West, young man!
The Wall Street Journal published a very interesting article on the shift in drug diversion trends within the United States. DEA has very publicly focused its enforcement efforts on South Florida pill mills as well as other problematic locations in the Eastern United States. According to information obtained by the Wall
2012 DEA Enforcement Actions: A Year in Review
While the Drug Enforcement Administration (“DEA”) prosecuted far fewer administrative actions in FY2012 than FY2011, the Agency nonetheless continued to be very active in investigating pharmaceutical diversion cases. The highly publicized and unprecedented actions taken by DEA in FY2012 provide valuable insight to where the DEA may focus its enforcement efforts in 2013. The “DEA